In June 2024, Junshi Biosciences convened the 2023 annual general meeting, the 2024 first class meeting of A shareholders and the 2024 first class meeting of H shareholders, and completed the election ...
The U.S. Food and Drug Administration approved Qfitlia for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult ...
Sanofi's subcutaneous, or under-the-skin, therapy helps prevent bleeding and lowers antithrombin, a protein that delays blood ...
A little-known federal agency that touches the lives of people across the United States by funding the 988 crisis line, ...
The map allows Texans to type in an address or zip code to see where the over-the-counter drug Narcan can be purchased or ...
The race is under way to make faster, cheaper and better GLP-1 drugs that will go beyond reducing obesity levels to treating ...
Incarcerated people are reporting that the abrupt changes are wreaking havoc on their health and mental well-being.
A decision on tolebrutinib for treating MS is now set for Sept. 28, after the FDA granted priority review to its approval ...
After a twitching pinky finger led to a diagnosis of young-onset Parkinson's disease, Keith Krehbiel, then 42, stopped at a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback